Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,573
+$5,036 QoQ
Shares Held
450
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,182
of 1,348 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KELLY LAWRENCE W & ASSOCIATES INC/CA holds $15,835,572 across 7 Drug Manufacturers - General names. NVO ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,610 | $12,091,511 | |
| 2 | ABBV |
AbbVie Inc.
|
7,791 | $1,960,527 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
6,044 | $763,598 | |
| 4 | AMGN |
Amgen Inc
|
1,398 | $506,243 | |
| 5 | LLY |
ELI LILLY & Co
|
227 | $272,270 | |
| 6 | PFE |
Pfizer Inc
|
9,130 | $219,850 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
450 | $21,573 |
All Filings in NVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,573 | 450 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $16,537 | 450 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $22,896 | 450 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $24,970 | 450 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $31,059 | 450 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $31,248 | 450 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $38,709 | 450 | Shares | Other | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||